key: cord-0691181-y2zx7wlh authors: An, Xiangjie; Song, Zexing; Gao, Yaoying; Tao, Juan; Yang, Jing title: To resume noninvasive imaging detection safely after peak period of COVID‐19: experiences from Wuhan China date: 2020-05-15 journal: Dermatol Ther DOI: 10.1111/dth.13590 sha: 39f57fbb161d8e5b20ee9f6f2a9053a0377c76ba doc_id: 691181 cord_uid: y2zx7wlh nan period of the epidemic, how to resume noninvasive imaging detectings safely is a concerning issue for both dermatologists and patients. Wuhan is the hardest-hit city by the COVID-19. After 3 months of circuit policy, large backlog patients made the resumption of noninvasive imaging tests urgent. However, the existence of asymptomatic and extended incubation period COVID-19 patients made difficulties in screening out all patients. Besides, the contact of scan probe with the patient's skin is unavoidable, and the SARS-CoV-2 was found capable of staying alive on such plastic or steel surfaces for 48-72 hours with the possible danger of crosstransmission of Consequently, the infection-control measures while resuming routine dermatologic care are still of great necessity. We take some practical safety measures in the stabilized epidemic period as the followings: 1. Weigh the potential risk of delaying detection against the COVID-19 infection to the patient according to the overall local epidemic situation, and then make the timeframe of resume the noninvasive imaging detection. On Januray 23, Wuhan city was lockdown, and our dermatology outpatient clinic was closed on the same day. From March 11, the number of new confirmed COVID-19 Figure 1 . Diagram of the "three zones and two passageways". The red indicate contaminated zone; the yellow indicate potential-contaminated zone and the blue indicate clean zone. The patients and staff get into the noninvasion imagine detection room by their respectively passageway. Noninvasive diagnosis in dermatology Art of performing dermoscopy during the times of coronavirus disease (COVID-19): simple change in approach can save the day! J Eur Acad Dermatol Venereol